299 related articles for article (PubMed ID: 27189286)
1. Vitamin D Repletion in Korean Postmenopausal Women with Osteoporosis.
Chung YS; Chung DJ; Kang MI; Kim IJ; Koh JM; Min YK; Oh HJ; Park IH; Lee YS; Kravitz B; Waterhouse B; Fitzpatrick LA; Nino A
Yonsei Med J; 2016 Jul; 57(4):923-7. PubMed ID: 27189286
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D status and response to treatment in post-menopausal osteoporosis.
Adami S; Giannini S; Bianchi G; Sinigaglia L; Di Munno O; Fiore CE; Minisola S; Rossini M
Osteoporos Int; 2009 Feb; 20(2):239-44. PubMed ID: 18551242
[TBL] [Abstract][Full Text] [Related]
4. Serum vitamin D status of Korean postmenopausal women during the winter months.
Lee ES; Ahn J; Park HM
Asia Pac J Clin Nutr; 2009; 18(1):29-33. PubMed ID: 19329392
[TBL] [Abstract][Full Text] [Related]
5. Maintenance vitamin D3 dosage requirements in Chinese women with post menopausal osteoporosis living in the tropics.
Venugopal Y; Hatta SFWM; Musa N; Rahman SA; Ratnasingam J; Paramasivam SS; Lim LL; Ibrahim L; Choong K; Tan AT; Chinna K; Chan SP; Vethakkan SR
Asia Pac J Clin Nutr; 2017 May; 26(3):412-420. PubMed ID: 28429905
[TBL] [Abstract][Full Text] [Related]
6. Dose response to vitamin D supplementation in postmenopausal women: a randomized trial.
Gallagher JC; Sai A; Templin T; Smith L
Ann Intern Med; 2012 Mar; 156(6):425-37. PubMed ID: 22431675
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
Rizzoli R; Boonen S; Brandi ML; Bruyère O; Cooper C; Kanis JA; Kaufman JM; Ringe JD; Weryha G; Reginster JY
Curr Med Res Opin; 2013 Apr; 29(4):305-13. PubMed ID: 23320612
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D status in a rural postmenopausal female population.
Lappe JM; Davies KM; Travers-Gustafson D; Heaney RP
J Am Coll Nutr; 2006 Oct; 25(5):395-402. PubMed ID: 17031008
[TBL] [Abstract][Full Text] [Related]
9. The effect of monthly 50,000 IU or 100,000 IU vitamin D supplements on vitamin D status in premenopausal Middle Eastern women living in Auckland.
Mazahery H; Stonehouse W; von Hurst PR
Eur J Clin Nutr; 2015 Mar; 69(3):367-72. PubMed ID: 25491499
[TBL] [Abstract][Full Text] [Related]
10. Are commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels--an observational study during clinical practice conditions.
Leidig-Bruckner G; Roth HJ; Bruckner T; Lorenz A; Raue F; Frank-Raue K
Osteoporos Int; 2011 Jan; 22(1):231-40. PubMed ID: 20556359
[TBL] [Abstract][Full Text] [Related]
11. Effect of isolated vitamin D supplementation on the rate of falls and postural balance in postmenopausal women fallers: a randomized, double-blind, placebo-controlled trial.
Cangussu LM; Nahas-Neto J; Orsatti CL; Poloni PF; Schmitt EB; Almeida-Filho B; Nahas EA
Menopause; 2016 Mar; 23(3):267-74. PubMed ID: 26554884
[TBL] [Abstract][Full Text] [Related]
12. Longevity of daily oral vitamin D3 supplementation: differences in 25OHD and 24,25(OH)2D observed 2 years after cessation of a 1-year randomised controlled trial (VICtORy RECALL).
Macdonald HM; Gryka A; Tang JCY; Aucott LS; Fraser WD; Wood AD
Osteoporos Int; 2017 Dec; 28(12):3361-3372. PubMed ID: 28916992
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of risedronate with cholecalciferol on 25-hydroxyvitamin D level and bone turnover in Korean patients with osteoporosis.
Chung HY; Chin SO; Kang MI; Koh JM; Moon SH; Yoon BK; Yoon HK; Chung YS; Park HM
Clin Endocrinol (Oxf); 2011 Jun; 74(6):699-704. PubMed ID: 21521310
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D status and response to daily 400 IU vitamin D3 and weekly alendronate 70 mg in men and women with osteoporosis.
Karaplis AC; Chouha F; Djandji M; Sampalis JS; Hanley DA
Ann Pharmacother; 2011 May; 45(5):561-8. PubMed ID: 21521859
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D status, dependence on age, and seasonal variations in the concentration of vitamin D in Croatian postmenopausal women initially screened for osteoporosis.
Laktasic-Zerjavic N; Korsic M; Crncevic-Orlic Z; Kovac Z; Polasek O; Soldo-Juresa D
Clin Rheumatol; 2010 Aug; 29(8):861-7. PubMed ID: 20204667
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer.
Nogues X; Servitja S; Peña MJ; Prieto-Alhambra D; Nadal R; Mellibovsky L; Albanell J; Diez-Perez A; Tusquets I
Maturitas; 2010 Jul; 66(3):291-7. PubMed ID: 20399042
[TBL] [Abstract][Full Text] [Related]
17. Correction of vitamin D insufficiency with combined strontium ranelate and vitamin D3 in osteoporotic patients.
Rizzoli R; Dawson-Hughes B; Kaufman JM; Fardellone P; Brandi ML; Vellas B; Collette J; Reginster JY
Eur J Endocrinol; 2014 Mar; 170(3):441-50. PubMed ID: 24322182
[TBL] [Abstract][Full Text] [Related]
18. Changes in vitamin D supplement use and baseline plasma 25-hydroxyvitamin D concentration predict 5-y change in concentration in postmenopausal women.
Kluczynski MA; Wactawski-Wende J; Platek ME; DeNysschen CA; Hovey KM; Millen AE
J Nutr; 2012 Sep; 142(9):1705-12. PubMed ID: 22833661
[TBL] [Abstract][Full Text] [Related]
19. The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass--a randomized controlled 1-year trial.
Grimnes G; Joakimsen R; Figenschau Y; Torjesen PA; Almås B; Jorde R
Osteoporos Int; 2012 Jan; 23(1):201-11. PubMed ID: 21909730
[TBL] [Abstract][Full Text] [Related]
20. Spectacular improvement in vitamin D status in elderly osteoporotic women: 8-year analysis of an osteoporotic population treated in a dedicated fracture liaison service.
Amouzougan A; Deygat A; Trombert B; Constant E; Denarié D; Marotte H; Thomas T
Osteoporos Int; 2015 Dec; 26(12):2869-75. PubMed ID: 26104797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
